AMY-101 (Cp40), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 (Cp40) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation[1][2].
Molecular Weight:
1789.09
Purity:
99.86
CAS Number:
[1427001-89-5]
Formula:
C83H117N23O18S2
Target:
Complement System,SARS-CoV
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted